calcium dobesilate has been researched along with Diabetes Mellitus, Type 2 in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (10.00) | 18.7374 |
| 1990's | 2 (20.00) | 18.2507 |
| 2000's | 3 (30.00) | 29.6817 |
| 2010's | 4 (40.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bogdanov, P; Garcia-Ramirez, M; Hernández, C; Pasquali, C; Sampedro, J; Simó, R; Solà-Adell, C; Valeri, M | 1 |
| Bogdanov, P; García-Ramírez, M; Hernández, C; Pasquali, C; Sampedro, J; Simó, R; Simó-Servat, O; Solà-Adell, C; Valeri, M | 1 |
| Han, K; Liu, C; Rao, X; Shi, X | 1 |
| Li, S; Mou, S; Ni, Z; Qi, C; Shao, X; Zhou, Y | 1 |
| Gerss, J; Haritoglou, C; Kampik, A; Sauerland, C; Ulbig, MW | 1 |
| Chiavaroli, C; Garay, RP; Lameynardie, S; Parés-Herbuté, N; Travo, P | 1 |
| Caillon, P; Carneiro, AM; Cunha-Vaz, JG; Ribeiro, ML; Seres, AI; Stur, M; Zourdani, A | 1 |
| García Benayas, E; García Díaz, B; Pérez, G | 1 |
| Guo, L; Zhong, H | 1 |
| Acciavatti, A; Burresi, A; Franchi, M; Frigerio, C; Galigani, C; Guerrini, M; Guideri, F; Landini, F; Messa, GL; Pieragalli, D | 1 |
5 trial(s) available for calcium dobesilate and Diabetes Mellitus, Type 2
| Article | Year |
|---|---|
Effects of alprostadil combined with calcium dobesilate in patients with diabetic peripheral neuropathy.
Topics: Aged; Aged, 80 and over; Alprostadil; Calcium Dobesilate; Diabetes Mellitus, Type 2; Diabetic Neuropathies; Drug Therapy, Combination; Female; Fibrinolytic Agents; Hemostatics; Humans; Male; Middle Aged; Peripheral Nervous System Diseases; Treatment Outcome | 2018 |
Diabetic Nephropathy Can Be Treated with Calcium Dobesilate by Alleviating the Chronic Inflammatory State and Improving Endothelial Cell Function.
Topics: Aged; Albuminuria; Anti-Inflammatory Agents; Calcium Dobesilate; Chronic Disease; Creatine; Cross-Sectional Studies; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Female; Glomerular Filtration Rate; Humans; Inflammation; Kidney Function Tests; Male; Middle Aged; Prospective Studies | 2018 |
Effect of calcium dobesilate on occurrence of diabetic macular oedema (CALDIRET study): randomised, double-blind, placebo-controlled, multicentre trial.
Topics: Adult; Aged; Analysis of Variance; Calcium Dobesilate; Diabetes Mellitus, Type 2; Diabetic Retinopathy; Disease Progression; Double-Blind Method; Female; Fluorescein Angiography; Follow-Up Studies; Hemostatics; Humans; Kaplan-Meier Estimate; Logistic Models; Macular Edema; Male; Middle Aged; Proportional Hazards Models; Risk Reduction Behavior; Severity of Illness Index; Time Factors | 2009 |
Effect of calcium dobesilate on progression of early diabetic retinopathy: a randomised double-blind study.
Topics: Adult; Aged; Blood-Retinal Barrier; Calcium Dobesilate; Capillary Permeability; Diabetes Mellitus, Type 2; Diabetic Retinopathy; Disease Progression; Double-Blind Method; Female; Fluorescein; Fluorescein Angiography; Fluorophotometry; Hemostatics; Humans; Male; Middle Aged; Pilot Projects; Visual Acuity; Vitreous Body | 2006 |
[Calcium dobesilate, hemorheology, fibrinolysis and endothelium. New perspectives on the prevention of diabetic microangiopathy. Clinical pharmacological study].
Topics: Administration, Oral; Benzenesulfonates; Blood Flow Velocity; Blood Viscosity; Calcium Dobesilate; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Double-Blind Method; Female; Humans; Injections, Intravenous; Male; Middle Aged | 1989 |
5 other study(ies) available for calcium dobesilate and Diabetes Mellitus, Type 2
| Article | Year |
|---|---|
Calcium Dobesilate Prevents Neurodegeneration and Vascular Leakage in Experimental Diabetes.
Topics: Animals; Apoptosis; Blotting, Western; Calcium Dobesilate; Cell Survival; Cells, Cultured; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Diabetic Retinopathy; Electroretinography; Enzyme-Linked Immunosorbent Assay; Gene Expression Regulation; Hemostatics; Humans; In Situ Nick-End Labeling; Male; Mice; Microscopy, Fluorescence; Oxidative Stress; Real-Time Polymerase Chain Reaction; Retina; Retinal Pigment Epithelium; RNA; Vascular Endothelial Growth Factor A | 2017 |
Calcium dobesilate prevents the oxidative stress and inflammation induced by diabetes in the retina of db/db mice.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Antioxidants; Biomarkers; Calcium Dobesilate; Cells, Cultured; Crosses, Genetic; Cytokines; Diabetes Mellitus, Type 2; Diabetic Retinopathy; Humans; I-kappa B Kinase; Male; Mice, Mutant Strains; Mice, Transgenic; Neuroprotective Agents; Oxidative Stress; Phosphorylation; Protein Processing, Post-Translational; Random Allocation; Retina; Retinitis | 2017 |
Inhibition of choroidal angiogenesis by calcium dobesilate in normal Wistar and diabetic GK rats.
Topics: Animals; Calcium Dobesilate; Choroid; Choroidal Neovascularization; Diabetes Mellitus, Type 2; Dose-Response Relationship, Drug; Female; Male; Rats; Rats, Wistar; Time Factors; Tissue Culture Techniques; Vascular Endothelial Growth Factor A | 2005 |
Calcium dobesilate-induced agranulocytosis.
Topics: Agranulocytosis; Calcium Dobesilate; Diabetes Mellitus, Type 2; Diabetic Retinopathy; Hemostatics; Humans; Male; Middle Aged | 1997 |
[The plasma levels of endothelin in diabetic retinopathy and their changes after treatment with doxium].
Topics: Adult; Aged; Calcium Dobesilate; Diabetes Mellitus, Type 2; Diabetic Retinopathy; Endothelins; Female; Hemostatics; Humans; Male; Middle Aged | 1997 |